XM
RGNX icon

XTX Markets’s Regenxbio RGNX Stock Holding History

XTX Markets’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$201K Buy
+4,427
New +$155K 0.41% 138

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Korea Investment Corp
Korea Investment Corp Seoul, South Korea $48.3B AUM 31.57% 1-Year Est. Return

XTX Markets's RGNX Position: Q4 2020 in Review

XTX Markets opened a new position in Regenxbio (RGNX) in Q4 2020: 4,427 shares worth $201K. The stake represents 0.41% of the portfolio and ranks #138 among its holdings.

187 funds tracked by Wall St. Rank hold RGNX as of Q4 2020.

  • XTX Markets held 4,427 shares of Regenxbio worth $201K as of Q4 2020.
  • Regenxbio was a new XTX Markets position in Q4 2020.
  • Regenxbio made up 0.41% of XTX Markets's portfolio in Q4 2020, its #138 holding.
  • 187 funds tracked by Wall St. Rank held Regenxbio as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.